Glomerular lesions in patients with sickle cell disease

Medicine

Volumn 89, Issue 1, 2010, Pages 18-27

  Maigne, Gwenola ^a   Ferlicot, Sophie ^b   Galacteros, Frederic ^d   Belenfant, Xavier ^f   Ulinski, Tim ^c   Niaudet, Patrick ^c   Ronco, Pierre ^g   Godeau, Bertrand ^e   Durrbach, Antoine ^c   Sahali, Sabrinel ^a   Lang, Philippe ^e   Lambotte, Olivier ^a   Audard, Vincent ^e  

^a Internal Medicine Unit   (United States)

^b Pathology Department   (United States)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d Sickle Cell Disease Center   (France)

^e HENRI MONDOR HOSPITAL   (France)

^f Hô Pital de Montreuil   (France)

^g HÔPITAL TENON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYUREA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ALBUMINURIA; ARTICLE; BLOOD TRANSFUSION; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HISTOPATHOLOGY; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY INJURY; LONG TERM CARE; MACROALBUMINURIA; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RENAL PROTECTION; RENOVASCULAR HYPERTENSION; SCHOOL CHILD; SICKLE CELL ANEMIA; SICKLE CELL DISEASE GLOMERULOPATHY; THROMBOTIC MICROANGIOPATHY GLOMERULOPATHY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; FEMALE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; MALE; THROMBOTIC MICROANGIOPATHIES;

EID: 74549147344     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/MD.0b013e3181ca59b6     Document Type: Article

References (32)

1. Alvarez O, Lopez-Mitnik G, Zilleruelo G. Short-term follow-up of patients with sickle cell disease and albuminuria. Pediatr Blood Cancer. 2008;50:1236-1239.
2. Aslan M, Ryan TM, Townes TM, Coward L, Kirk MC, Barnes S, Alexander CB, Rosenfeld SS, Freeman BA. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem. 2003;278:4194-4204.
3. Ataga KI, Orringer EP. Renal abnormalities in sickle cell disease. Am J Hematol. 2000;63:205-211.
4. Bakir AA, Hathiwala SC, Ainis H, Hryhorczuk DO, Rhee HL, Levy PS, Dunea G. Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study. Am J Nephrol. 1987;7: 110-115.
5. Bank N, Kiroycheva M, Ahmed F, Anthony GM, Fabry ME, Nagel RL, Singhal PC. Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int. 1998;54:1520-1528.
6. Berstein J, Whitten CF. A histologic appraisal of the kidney in sickle cell anemia. Arch Pathol. 1960;70:407-418.
7. Bhathena DB, Sondheimer JH. The glomerulopathy of homozygous sickle hemoglobin (SS) disease: morphology and pathogenesis. J Am Soc Nephrol. 1991;1:1241-1252.
8. D'Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368-382.
9. D'Agati VD, Jennette JC, Silva FG. Membranoproliferative glomerulonephritis. In: West King D, ed. Non-Neoplastic Kidney Disease. Washington, DC: American Registry of Pathology, Armed Forces Institute of Pathology; 2005.
10. D'Agati VD, Jennette JC, Silva FG. Thrombotic microangiopathies and coagulopathies. In: West King D, ed. Non-Neoplastic Kidney Disease. Washington, DC: American Registry of Pathology, Armed Forces Institute of Pathology; 2005.
11. Elfenbein IB, Patchefsky A, Schwartz W, Weinstein AG. Pathology of the glomerulus in sickle cell anemia with and without nephrotic syndrome. Am J Pathol. 1974;77:357-374.
12. Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC. Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med. 1992;326:910-915.
13. Finn LS, Bernstein J. Renal disease caused by familial metabolic and hematologic diseases. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. Philadelphia: Lippincott Williams & Wilkins; 2007.
14. Garcia-Monzon C, Majano PL, Zubia I, Sanz P, Apolinario A, Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol. 2000;32:331-338.
15. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, Brown B, Coles WA, Nichols JS, Ernst I, Hunter LA, Blackwelder WC, Schechter AN, Rodgers GP, Castro O, Ognibene FP. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350:886-895.
16. Guasch A, Navarrete J, Nass K, Zayas CF. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J Am Soc Nephrol. 2006;17:2228-2235.
17. Kiroycheva M, Ahmed F, Anthony GM, Szabo C, Southan GJ, Bank N. Mitogen-activated protein kinase phosphorylation in kidneys of beta(s) sickle cell mice. J Am Soc Nephrol. 2000;11:1026-1032.
18. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007;25:1751-1762.
19. McCoy RC. Ultrastructural alterations in the kidney of patients with sickle cell disease and the nephrotic syndrome. Lab Invest. 1969;21:85-95.
20. Mohammed NA, Abd El-Aleem S, Appleton I, Maklouf MM, Said M, McMahon RF. Expression of nitric oxide synthase isoforms in human liver cirrhosis. J Pathol. 2003;200:647-655.
21. Nasr SH, Markowitz GS, Sentman RL, D'Agati VD. Sickle cell disease, nephrotic syndrome, and renal failure. Kidney Int. 2006;69:1276-1280.
22. Pardo V, Strauss J, Kramer H, Ozawa T, McIntosh RM. Nephropathy associated with sickle cell anemia: an autologous immune complex nephritis. II. Clinicopathologic study of seven patients. Am J Med. 1975;59:650-659.
23. Pitcock JA, Muirhead EE, Hatch FE, Johnson JG, Kelly BJ. Early renal changes in sickle cell anemia. Arch Pathol. 1970;90:403-410.
24. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330:1639-1644.
25. Powars DR, Chan LS, Hiti A, Ramicone E, Johnson C. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine (Baltimore). 2005;84:363-376.
26. Powars DR, Elliott-Mills DD, Chan L, Niland J, Hiti AL, Opas LM, Johnson C. Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality. Ann Intern Med. 1991;115:614-620.
27. Saborio P, Scheinman JI. Sickle cell nephropathy. J Am Soc Nephrol. 1999;10:187-192.
28. Scheinman JI. Sickle cell disease and the kidney. Semin Nephrol. 2003;23:66-76.
29. Schmitt F, Martinez F, Brillet G, Giatras I, Choukroun G, Girot R, Bachir D, Galacteros F, Lacour B, Grunfeld JP. Early glomerular dysfunction in patients with sickle cell anemia. Am J Kidney Dis. 1998;32:208-214.
30. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet. 2004;364:1343-1360.
31. Vogler C, Wood E, Lane P, Ellis E, Cole B, Thorpe C. Microangiopathic glomerulopathy in children with sickle cell anemia. Pediatr Pathol Lab Med. 1996;16:275-284.
32. Wesson DE. The initiation and progression of sickle cell nephropathy. Kidney Int. 2002;61:2277-2286.